Albany Molecular Res (AMRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Sales | 61,365 | 57,935 | 53,570 | 47,223 | 47,557 |
| Cost of Goods | 39,327 | 34,368 | 37,047 | 33,812 | 34,003 |
| Gross Profit | 22,038 | 23,567 | 16,523 | 13,411 | 13,554 |
| Operating Expenses | 13,618 | 14,948 | 12,253 | 15,473 | 11,420 |
| Operating Income | 8,747 | 8,987 | 4,317 | -1,250 | 2,137 |
| Other Income | 748 | 464 | 463 | 787 | 693 |
| Pre-tax Income | 9,495 | 9,451 | 4,780 | -463 | 2,830 |
| Income Tax | 2,492 | 3,774 | 41 | 381 | 850 |
| Net Income Continuous | 7,003 | 5,677 | 4,739 | -844 | 1,980 |
| Net Income | $7,003 | $5,677 | $4,739 | $-844 | $1,980 |
| EPS Basic Total Ops | 0.22 | 0.18 | 0.15 | -0.02 | 0.06 |
| EPS Basic Continuous Ops | 0.22 | 0.18 | 0.15 | -0.03 | 0.06 |
| EPS Diluted Total Ops | 0.22 | 0.18 | 0.15 | -0.03 | 0.06 |
| EPS Diluted Continuous Ops | 0.22 | 0.18 | 0.15 | -0.03 | 0.06 |
| EBITDA(a) | $13,095 | $13,505 | $8,922 | $3,083 | $6,446 |